Építés alatt – nem éles oldal
Belépés

NCT06624137Leállítva

Computer Game, Qualitative, and MEG/EEG Assessment of Serotonergic Psychedelics

Computationally, Electrophysiologically, and Qualitatively Characterizing Serotonergic Psychedelics; Transdiagnostic Therapeutic and Pro-Psychotic Effects

Forrás: ClinicalTrials.gov · Utoljára frissítve: 2026. júl. 9.

Megadott ok: Funding ended.

Rövid összefoglaló (regiszter, angolul)

This is an observational study which does NOT directly administer a psychedelic substance but rather recruits participants who are already participating in another clinical trial in which they may receive a serotonergic psychedelic. The goal of this observational study is to learn how the brain's information processing changes during and following administration of serotonergic psychedelics (psilocybin, N,N-Dimethyltryptamine/DMT, Lystergic Acid Diethylamide/LSD, etc.) for people with and without mental illness receiving serotonergic psychedelics through any clinical trial at Yale University. The main questions it aims to answer are: 1. Do serotonergic psychedelics cause the brain to rely on new information more than previously learned information while under the influence? What about 1 day, 5-14 days, and 4-6 weeks after use? 2. Do serotonergic psychedelics cause long-lasting side-effects in how people perceive (see, hear, feel, etc.) the world and how easily people change their beliefs? 3. How does the brain's electrical activity change after using serotonergic psychedelics? How does the balance between excitation and inhibition change while under their effect? 4. Can changes in how the brain uses information predict who will benefit from a psychedelic and who will have side effects from psychedelics? Researchers will compare with people given placebos to see what changes in brain processing are unique to serotonergic psychedelics. Participants will have the opportunity to do some combination of the following: 1. Online computer assessments consisting of games and questionnaires that probe how participants think. 2. Magnetoencephalography (MEG) or electroencephalography (EEG) with eyes closed and with repeated clicks, images, or sensations delivered. 3. A magnetic resonance imaging (MRI) scan. 4. Semi-structured qualitative interviews about their experience after taking a serotonergic psychedelic recorded via Zoom.

Állapot (regiszter)
Leállítva
Vizsgálattípus
Megfigyeléses
Résztvevők száma
5 (tényleges)
Első benyújtás
2024. szept. 30.
Kezdés
2024. dec. 12.
Elsődleges befejezés
2026. jún. 14.
Fő szponzor
Yale University
Betegségek
Depresszió, Migrén
NCT-szám
NCT06624137

Ki nem vehet részt

Szó szerint a(z) ClinicalTrials.gov forrásból, témák szerint csoportosítva. Hogy ki vehet részt, azt csak a vizsgálat csapata dönti el.

Más betegség

  • History of seizures based on self-report
  • Contraindications for MR scanning including metallic implants of any kind, pacemakers and history of accidents with metal, claustrophobia (specific to those who will participate in MRI)

Egyéb

  • Current intoxication based on self-report
  • Any neurological, medical or developmental problem that is known to impair cognition significantly based on self-report

Kiket keres a vizsgálat

  • Participation in approved clinical protocol at Yale University involving potential administration of serotonergic psychedelics
  • Absence of pre-existing psychotic symptoms

Életkor a regiszterben: 18 év – 65 év · Nem: nők és férfiak · Egészséges önkénteseket is fogad

A teljes feltétellista: ClinicalTrials.gov

Helyszínek (2)

Helyszínek a regiszter sorrendjében. Ha a profilodba mented a városodat, távolság szerint rendeződnek.

HelyszínVárosOrszágHelyszín állapota
Connecticut Mental Health CenterHamdenEgyesült ÁllamokIsmeretlen állapot
West Haven VA Medical CenterWest HavenEgyesült ÁllamokIsmeretlen állapot

Te vagy a koordinátor? Erősítsd meg az adatokat

Ez az oldal tájékoztatás, nem orvosi tanács. Bármely vizsgálatról az orvosoddal beszélj.